Loading clinical trials...
Loading clinical trials...
The Canadian Study of Arterial Inflammation in Patients With Diabetes and Recent Vascular Events: EvaluatioN of Colchicine Effectiveness (CADENCE)
Conditions
Interventions
Colchicine Oral Product
Placebo oral capsule
Locations
2
Canada
Mazankowski Alberta Heart Institute
Edmonton, Alberta, Canada
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Start Date
August 1, 2020
Primary Completion Date
August 14, 2024
Completion Date
August 14, 2025
Last Updated
April 22, 2024
NCT07543666
NCT07550023
NCT07547774
NCT07547098
NCT01399385
NCT04888923
Lead Sponsor
Ottawa Heart Institute Research Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions